Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 17, Issue 1, 2003, Pages 1-6

  Yang, Bingmei ^a   Cross, Deborah F ^a   Ollerenshaw, Martin ^a   Millward, Beverly A ^a   Demaine, Andrew G ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Aldose reductase; Diabetic microvascular complications; Type 1 diabetes; VEGF

Indexed keywords

ALDEHYDE REDUCTASE; LUCIFERASE; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BASE PAIRING; CELL STRAIN HEPG2; CHILD; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GENE CONSTRUCT; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PATHOGENESIS; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

ADULT; ALDEHYDE REDUCTASE; ALLELES; BASE PAIRING; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037227999     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00181-2     Document Type: Article

References (42)

1. Adler S.G., Pahl M., Seldin M.F. Deciphering diabetic nephropathy: progress using genetic strategies. Current Opinion in Nephrology and Hypertension. 9:2000;99-106.
2. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine. 331:1994;1480-1487.
3. Aillo L.P., Wong J.S. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney International. 77:2000;S113-S119.
4. Andersen A.R., Christiansen J.S., Andersen J.K., Kreiner S., Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 25:1993;496-501.
5. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Human Immunology. 60:1999;1245-1249.
6. Brown L.F., Berse B., Tognazzi K., Manseau E.J., Van de Water L., Senger D.R., Dvorak H.F., Rosen S. Vascular endothelial growth factor mRNA and protein expression in human kidney. Kidney International. 142:1992;1457-1461.
7. Cha D.R., Kim N.H., Yoon J.W., Jo S.K., Cho W.Y., Kim H.K., Won N.H. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney International. 58(Suppl. 77):2000;S104-S112.
8. Chiarelli F., Spagnoli A., Basciani F., Tumini S., Mezzetti A., Cipollone F., Cuccurullo F., Morgess G., Verrotti A. Diabetic Medicine. 17:2000;650-656.
9. Chowdhury T.A., Kumar S., Barnett A.H., Bain S.C. Nephropathy in type 1 diabetes: the role of genetic factors. Diabetic Medicine. 12:1995;1059-1067.
10. Cooper M.E., Vranes D., Youssef S., Stacker S.A., Cox A.J., Rizkalla B., Casley D.J., Bach L.B., Kelly D.J., Gilbert R.E. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 48:1999;2229-2239.
11. The effect of intensive insulin treatment of diabetes in the development and progression of long-term complications of insulin-dependent diabetes mellitus. New England Journal of Medicine. 329:1993;977-986.
12. De Vriese A.S., Tilton R.G., Elger M., Stephan C.C., Kriz W., Lameire N.H. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. Journal of the American Society of Nephrology. 12:2001;993-1000.
13. Del Prete D., Angelani F., Ceol M., D'Angelo A., Forino M., Vianello D., Baggio B., Cambaro G. Molecular biology of diabetic glomerulosclerosis. Nephrology, Dialysis, Transplantation. 13(Suppl. 8):1998;20-25.
14. Demaine A., Cross D., Millward B.A. Polymorphisms of the aldose reductase gene susceptibility to retinopathy in type 1 diabetes mellitus. Investigative Ophthalmology & Visual Science. 41:2000;4064-4068.
15. Doria A., Warram J.H., Krolewski A.S. Genetic susceptibility to nephropathy in insulin-dependent diabetes: from epidemiology to molecular genetics. Diabetes Metabolic Review. 11:1995;281-287.
16. Gilbert R.E., Vranes D., Berka J.L., Kelly D.J., Cox A., Wu L.L., Stacker S.A., Cooper M.E. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Laboratory Investigation. 78:1998;1017-1027.
17. Gröne H.J. Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients? Nephrology, Dialysis, Transplantation. 10:1995;761-763.
18. Heesom A.E., Hibberd M.L., Millward B.A., Demaine A.G. A polymorphism at the 5′ end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type 1 diabetes. Diabetes. 46:1997;287-291.
19. Hodgkinson A.D., Sondergaard K.L., Yang B., Cross D.F., Millward B.A., Demaine A.G. Aldose reductase expression is induced by hyperglycaemia in diabetic nephropathy. Kidney International. 60:2001;211-218.
20. Hovind P., Tarnow L., Oestergaard P.B., Parving H.H. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney International. 57(Suppl. 75):2000;S56-S61.
21. Kim N.H., Jung H.H., Cha D.R., Choi D.S. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. Journal of Endocrinology. 165:2000;617-624.
22. Lijima K., Yoshikawa N., Connolly D.T., Nakamura H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney International. 44:1993;959-966.
23. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circulation Research. 77:1995;638-643.
24. Moczulski D.K., Scott L., Antonellis A., Rogus J.J., Rich S.S., Warram J.H., Krolewski A.S. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabetic Medicine. 17:2000;111-118.
25. Molitch M.E. The relationship between glucose control and the development of diabetic nephropathy in type 1 diabetes. Seminars in Nephrology. 17:1997;101-103.
26. Molyneaux L.M., Constantino M.I., McGill M., Zilkens R., Yue D.K. Better glycaemic control and risk reduction of diabetic complications in type 2 diabetes: comparison with the DCCT. Diabetes Research and Clinical Practice. 42:1998;77-83.
27. Murata T., Ishibashi K., Khalil A., Hata Y., Yoshikawa H., Inomata H. Vascular endothelial growth factor play a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Research. 27:1995;48-52.
28. Olmos P., Futers S., Acosta A.M., Siegel S., Maiz A., Schiaffino R., Morales P., Diaz R., Arriagada P., Claro J.C., Vega R., Vollrath V., Velasco S., Emmerich M. (AC)23 [Z-2] polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetes. Diabetes Research and Clinical Practice. 47:2000;169-176.
29. Parving H.H., Tarnow L., Rossing P. Genetics of diabetic nephropathy. Journal of the American Society of Nephrology. 7:1996;2509-2517.
30. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial factor is associated with vascular endothelial growth factor plasma levels. Journal of Vascular Research. 37:2000;443-448.
31. Shah V.O., Scavini M., Nikolic J., Sun Y., Vai S., Griffith J.K., Dorin R.I., Stidley C., Yacoub M., Vander Jagt D.J., Eaton R.P., Zager P.G. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. Journal of Clinical Endocrinology and Metabolism. 83:1998;2886-2891.
32. Shweki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
33. Simon E., Gröne H.J., Johren O., Kullmer J., Plate K.H., Risau W., Fuchs E. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. American Journal of Physiology. 268:1995;240-250.
34. Sone H., Kawakami Y., Lkuda Y., Kondo S., Hanatani M., Suzuki H., Yamashita K. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochemical and Biophysical Research Communications. 221:1996;193-198.
35. Steffes M.W. Glycemic control and the initiation and progression of the complications of diabetes mellitus. Kidney International, Supplement. 63:1997;S36-S39.
36. Stevens M.J., Feldman E.L., Greene D.A. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabetic Medicine. 12:1995;566-579.
37. Tilton R.G., Kakahiko T., Chang K.C., Ido Y., Bjercke R.J., Stephan C.C., Brock T.A., Williamson J.R. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. Journal of Clinical Investigation. 99:1997;2192-2202.
38. Tiwari J.L., Terasaki P.I. The Data and Statistical Analysis in HLA and Disease Associations. Tiwari J.L., Terasaki P.I. 1985;18-27 Springer-Verlag, New York.
39. Tsuzuki Y., Fukumura D., Oosthuyse B., Koike C., Carmeliet P., Jain R.K. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α hypoxia response element VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Research. 60:2000;6248-6252.
40. Watson C.J., Webb N.J.A., Bottomley M.J., Brenchley P.E.C. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 12:2000;1232-1235.
41. Williams B. Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissue. Diabetologia. 40(Suppl. 2):1997;118-120.
42. Willimson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J.R., Van den Enden M., Kilo C., Tilton R.G. Perspectives in diabetes: hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:1993;801-813.